Indication

Actinic keratosis

Actinic keratosis, also referred to as solar keratosis, is a common premalignant cutaneous neoplasm that arises within the epidermis due to cumulative ultraviolet radiation exposure. Read more about Actinic keratosis

54 drugs 34 manufacturers

Advertisement

Drugs that treat it

Common Actinic keratosis therapies.

Showing 28–36 of 54 drugs

IMIQUIMOD

EXTERNAL CONDYLOMATA ACUMINATA·+2
L Perrigo Company

IMIQUIMOD

EXTERNAL CONDYLOMATA ACUMINATA·+2
GLOBAL/IMPAX

IMIQUIMOD

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES·EXTERNAL CONDYLOMATA ACUMINATA·+1
OCEANSIDE PHARM

FLUOROURACIL

SUPERFICIAL BASAL CELL CARCINOMA·+1
SPEAR PHARM/MAY
Filter & compare in the drug finder →Opens the drug finder with Actinic keratosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Actinic keratosis.

Actinic keratosis, also referred to as solar keratosis, is a common premalignant cutaneous neoplasm that arises within the epidermis due to cumulative ultraviolet radiation exposure.

The condition predominantly affects fair-skinned, older, or immunocompromised individuals across chronically sun-exposed anatomical sites such as the face, scalp, ears, forearms, and dorsal hands.

Clinically, lesions present as rough, gritty, erythematous, or hyperkeratotic papules and plaques.

Pathophysiologically, it is characterized by atypical keratinocyte proliferation, nuclear pleomorphism, and architectural disorganization within the epidermis, carrying an intrinsic potential to progress to invasive cutaneous squamous cell carcinoma.

Personalize your experience

Follow Actinic keratosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it